Josh Chong has a extensive background in market planning, corporate strategy, and commercial strategy. With experience in various leadership roles at companies such as Summit Therapeutics, Nurix Therapeutics, and Genentech, Josh has a proven track record of success in the healthcare industry. Josh holds degrees from Stanford University and the University of Michigan in Executive Education, Business, Bachelor of Science in Management Science and Industrial Engineering, and Master of Science in Management Science and Industrial Engineering.
April, 2024 - present
June, 2023